Spectral Instruments Imaging v. Scintica: Settlement Reached in Molecular Imaging Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Spectral Instruments Imaging, LLC v. Scintica, Inc. et al. |
| Case Number | 4:22-cv-00043 (S.D. Tex.) |
| Court | Southern District of Texas |
| Duration | Jan 2022 – Aug 2024 950 days |
| Outcome | Case Settled — Confidential Terms |
| Patents at Issue | |
| Accused Products | Scintica’s Vilber Newton 7.0 imaging system |
Case Overview
The Parties
⚖️ Plaintiff
A developer of molecular imaging devices used in preclinical research, offering a portfolio of bioluminescence and fluorescence imaging systems widely used in academic and pharmaceutical research settings. Its patented technology represents core IP in a competitive, specialized market.
🛡️ Defendant
An international network of companies distributing and commercializing preclinical imaging equipment, including Bio Imaging Asia PTE. LTD, Bio Imaging SAS, and Scintica Instrumentation Inc.
Patents at Issue
This settlement involved U.S. Patent No. 8,901,516 B2, covering technology integral to in vivo molecular imaging systems. This patent protects core technology foundational to preclinical research workflows, making it commercially valuable in a competitive, specialized market.
- • US 8,901,516 B2 — Technology integral to in vivo molecular imaging systems
Developing a molecular imaging product?
Check if your design might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
The case concluded with a court-ordered dismissal without prejudice on August 13, 2024, after the parties notified the Southern District of Texas that a negotiated settlement had been reached. Specific financial terms remain confidential, a common feature of IP settlements in competitive technology sectors.
Key Legal Issues
The underlying cause of action was a direct patent infringement claim under 35 U.S.C. § 271. The dispute highlights the complexities of multi-defendant patent strategy, venue selection in Texas, and the commercial calculus driving settlement in high-stakes IP disputes within the life sciences instrumentation sector.
Freedom to Operate (FTO) Analysis for Molecular Imaging
This settlement highlights critical IP risks in the specialized molecular imaging market. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this technology space
- See which companies are most active in molecular imaging IP
- Understand claim construction patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
In vivo optical imaging systems
Patent Scope Unresolved
US 8,901,516 B2
Strategic Design-Around
Options for detection technology
✅ Key Takeaways from Spectral Instruments Imaging v. Scintica
Multi-defendant infringement cases with international co-defendants significantly increase duration and cost; early settlement analysis is advisable.
Search related case law →Dismissal without prejudice protects plaintiff IP leverage during post-settlement documentation periods.
Explore precedents →Frequently Asked Questions about Molecular Imaging IP
The case involved U.S. Patent No. 8,901,516 B2 (Application No. US13/222688), covering molecular imaging technology applicable to preclinical in vivo optical imaging systems.
The case was dismissed without prejudice on August 13, 2024, following the parties’ notification to the Southern District of Texas that a settlement had been reached. Financial terms were not publicly disclosed.
Because no merits ruling was issued, the ‘516 patent’s claim scope remains untested by judicial construction — leaving uncertainty for competitors and creating continued enforcement leverage for Spectral Instruments Imaging.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References & Further Reading
- United States District Court for the Southern District of Texas — Case 4:22-cv-00043 (PACER)
- U.S. Patent and Trademark Office — U.S. Patent No. 8,901,516 B2
- Cornell Legal Information Institute — 35 U.S.C. § 271
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.